UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $248.13 Million Stock Holdings in Humana Inc. (NYSE:HUM)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 14.1% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 978,010 shares of the insurance provider's stock after buying an additional 121,056 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.81% of Humana worth $248,131,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in the stock. Vanguard Group Inc. raised its position in Humana by 15.8% in the fourth quarter. Vanguard Group Inc. now owns 12,829,210 shares of the insurance provider's stock worth $3,254,899,000 after purchasing an additional 1,751,857 shares in the last quarter. Dodge & Cox raised its holdings in shares of Humana by 106.7% in the 4th quarter. Dodge & Cox now owns 10,198,040 shares of the insurance provider's stock worth $2,587,345,000 after buying an additional 5,264,045 shares in the last quarter. Pzena Investment Management LLC lifted its position in shares of Humana by 44.0% during the 4th quarter. Pzena Investment Management LLC now owns 3,609,382 shares of the insurance provider's stock worth $915,736,000 after buying an additional 1,103,132 shares during the period. Geode Capital Management LLC lifted its position in shares of Humana by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 2,883,614 shares of the insurance provider's stock worth $729,658,000 after buying an additional 63,562 shares during the period. Finally, Invesco Ltd. boosted its stake in Humana by 29.8% in the 4th quarter. Invesco Ltd. now owns 2,397,808 shares of the insurance provider's stock valued at $608,348,000 after buying an additional 550,692 shares in the last quarter. Institutional investors own 92.38% of the company's stock.

Analyst Ratings Changes

A number of brokerages have issued reports on HUM. Guggenheim began coverage on Humana in a report on Wednesday, April 9th. They set a "buy" rating and a $326.00 price objective for the company. Oppenheimer boosted their price target on shares of Humana from $300.00 to $310.00 and gave the company an "outperform" rating in a research report on Thursday, May 1st. Cantor Fitzgerald reaffirmed a "neutral" rating and set a $290.00 price objective on shares of Humana in a report on Thursday, May 1st. Mizuho boosted their target price on Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. Finally, Royal Bank of Canada restated an "outperform" rating and issued a $283.00 price objective on shares of Humana in a research report on Wednesday, February 12th. Seventeen research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $286.81.

Humana Stock Performance

HUM stock traded up $1.01 during midday trading on Tuesday, reaching $225.94. 968,259 shares of the company were exchanged, compared to its average volume of 1,777,620. Humana Inc. has a one year low of $212.45 and a one year high of $406.46. The firm has a market capitalization of $27.27 billion, a price-to-earnings ratio of 22.71, a price-to-earnings-growth ratio of 2.05 and a beta of 0.49. The business has a 50-day moving average price of $260.33 and a two-hundred day moving average price of $268.05. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, topping the consensus estimate of $10.07 by $1.51. Humana had a net margin of 1.02% and a return on equity of 11.70%. The business had revenue of $32.11 billion during the quarter, compared to the consensus estimate of $32 billion. During the same quarter in the previous year, the firm posted $7.23 EPS. Humana's revenue was up 8.4% compared to the same quarter last year. Equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 27th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.57%. Humana's payout ratio is 25.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.